{"id":"https://openalex.org/W1991969856","doi":"https://doi.org/10.1592/phco.30.5.463","title":"Dipeptidyl Peptidase\u20104 Inhibitors for the Treatment of Type 2 Diabetes Mellitus","display_name":"Dipeptidyl Peptidase\u20104 Inhibitors for the Treatment of Type 2 Diabetes Mellitus","alternate_titles":[],"publication_year":2010,"publication_date":"2010-04-23","ids":{"openalex":"https://openalex.org/W1991969856","doi":"https://doi.org/10.1592/phco.30.5.463","mag":"1991969856","pmid":"https://pubmed.ncbi.nlm.nih.gov/20411998"},"language":"en","primary_location":{"id":"doi:10.1592/phco.30.5.463","doi":"https://doi.org/10.1592/phco.30.5.463","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.30.5.463","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1991969856"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082350484","display_name":"Joshua J. Neumiller","orcid":"https://orcid.org/0000-0002-4734-7402","observed_orcids":["https://orcid.org/0000-0002-4734-7402"]},"institutions":[{"id":"https://openalex.org/I170632171","display_name":"Washington State University Spokane","ror":"https://ror.org/04vfs5h36","country_code":"US","type":"education","lineage":["https://openalex.org/I170632171","https://openalex.org/I72951846"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Joshua J. Neumiller","raw_affiliation_strings":["Department of Pharmacotherapy, Washington State University, and Elder Services, Spokane, Washington 99217, USA. jneumiller@wsu.edu","Department of Pharmacotherapy, Washington State University, Spokane, Washington","Elder Services, Spokane, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacotherapy, Washington State University, and Elder Services, Spokane, Washington 99217, USA. jneumiller@wsu.edu","institution_ids":["https://openalex.org/I170632171"]},{"raw_affiliation_string":"Department of Pharmacotherapy, Washington State University, Spokane, Washington","institution_ids":["https://openalex.org/I170632171"]},{"raw_affiliation_string":"Elder Services, Spokane, Washington","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041517508","display_name":"Lindy D. Wood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170632171","display_name":"Washington State University Spokane","ror":"https://ror.org/04vfs5h36","country_code":"US","type":"education","lineage":["https://openalex.org/I170632171","https://openalex.org/I72951846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lindy Wood","raw_affiliation_strings":["Department of Pharmacotherapy, Washington State University, Spokane, Washington","Elder Services, Spokane, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacotherapy, Washington State University, Spokane, Washington","institution_ids":["https://openalex.org/I170632171"]},{"raw_affiliation_string":"Elder Services, Spokane, Washington","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087170338","display_name":"R. Keith Campbell","orcid":"https://orcid.org/0009-0001-9734-1762","observed_orcids":["https://orcid.org/0009-0001-9734-1762"]},"institutions":[{"id":"https://openalex.org/I72951846","display_name":"Washington State University","ror":"https://ror.org/05dk0ce17","country_code":"US","type":"education","lineage":["https://openalex.org/I72951846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Keith Campbell","raw_affiliation_strings":["Department of Pharmacotherapy, Washington State University, Pullman, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacotherapy, Washington State University, Pullman, Washington","institution_ids":["https://openalex.org/I72951846"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5082350484"],"corresponding_institution_ids":["https://openalex.org/I170632171"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":12.6206,"has_fulltext":false,"cited_by_count":157,"citation_normalized_percentile":{"value":0.99190189,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"30","issue":"5","first_page":"463","last_page":"484"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.972000002861023},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":1.0},{"id":"https://openalex.org/keywords/saxagliptin","display_name":"saxagliptin","score":1.0},{"id":"https://openalex.org/keywords/alogliptin","display_name":"alogliptin","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7919999957084656},{"id":"https://openalex.org/keywords/drug-efficacy","display_name":"drug efficacy","score":0.6079999804496765},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9169999957084656},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.6700000166893005},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.8610000014305115},{"id":"https://openalex.org/keywords/hypoglycemia-risk","display_name":"hypoglycemia risk","score":0.8230000138282776},{"id":"https://openalex.org/keywords/weight-neutrality","display_name":"weight neutrality","score":0.5870000123977661}],"concepts":[{"id":"https://openalex.org/C2780012697","wikidata":"https://www.wikidata.org/wiki/Q4734170","display_name":"Alogliptin","level":5,"score":0.9556583762168884},{"id":"https://openalex.org/C2780282729","wikidata":"https://www.wikidata.org/wiki/Q3121121","display_name":"Saxagliptin","level":5,"score":0.9436025619506836},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8213660717010498},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.7488834857940674},{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.734701931476593},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.687560498714447},{"id":"https://openalex.org/C2780031085","wikidata":"https://www.wikidata.org/wiki/Q909745","display_name":"Linagliptin","level":4,"score":0.6325384378433228},{"id":"https://openalex.org/C2778176773","wikidata":"https://www.wikidata.org/wiki/Q2976049","display_name":"Drug class","level":3,"score":0.6027998328208923},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5547065138816833},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.549128532409668},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.5073322653770447},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4659871459007263},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.45566099882125854},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.43113410472869873},{"id":"https://openalex.org/C2778763485","wikidata":"https://www.wikidata.org/wiki/Q419770","display_name":"Dipeptidyl peptidase-4 inhibitor","level":4,"score":0.4170725345611572},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3731847107410431},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.33552372455596924},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.21467599272727966}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018819","descriptor_name":"Dipeptidyl Peptidase 4","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050417","descriptor_name":"Insulin-Secreting Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1592/phco.30.5.463","doi":"https://doi.org/10.1592/phco.30.5.463","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.30.5.463","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},{"id":"pmid:20411998","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20411998","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":112,"referenced_works":["https://openalex.org/W195141601","https://openalex.org/W1526927233","https://openalex.org/W1905803407","https://openalex.org/W1964212912","https://openalex.org/W1970406523","https://openalex.org/W1971471384","https://openalex.org/W1972127700","https://openalex.org/W1973383046","https://openalex.org/W1973976170","https://openalex.org/W1975582407","https://openalex.org/W1975588287","https://openalex.org/W1976026431","https://openalex.org/W1976403777","https://openalex.org/W1976509155","https://openalex.org/W1977619586","https://openalex.org/W1984588810","https://openalex.org/W1986044732","https://openalex.org/W1989976483","https://openalex.org/W1991565451","https://openalex.org/W1992966015","https://openalex.org/W1994743271","https://openalex.org/W1994832750","https://openalex.org/W2002937262","https://openalex.org/W2004977380","https://openalex.org/W2013910816","https://openalex.org/W2018192866","https://openalex.org/W2020638064","https://openalex.org/W2027249582","https://openalex.org/W2028707869","https://openalex.org/W2029084557","https://openalex.org/W2030861315","https://openalex.org/W2032254224","https://openalex.org/W2032322539","https://openalex.org/W2035705525","https://openalex.org/W2038445107","https://openalex.org/W2039779698","https://openalex.org/W2042457844","https://openalex.org/W2046335747","https://openalex.org/W2047353065","https://openalex.org/W2048453661","https://openalex.org/W2051462052","https://openalex.org/W2054185381","https://openalex.org/W2054564814","https://openalex.org/W2063976195","https://openalex.org/W2064410761","https://openalex.org/W2064780710","https://openalex.org/W2064900976","https://openalex.org/W2074956966","https://openalex.org/W2075182875","https://openalex.org/W2076721868","https://openalex.org/W2078561985","https://openalex.org/W2079787842","https://openalex.org/W2080128749","https://openalex.org/W2080866420","https://openalex.org/W2081733901","https://openalex.org/W2084403835","https://openalex.org/W2085862152","https://openalex.org/W2087063469","https://openalex.org/W2093528927","https://openalex.org/W2097893376","https://openalex.org/W2099604781","https://openalex.org/W2099677425","https://openalex.org/W2101246901","https://openalex.org/W2103058881","https://openalex.org/W2106154942","https://openalex.org/W2108646653","https://openalex.org/W2108771199","https://openalex.org/W2109157463","https://openalex.org/W2109728760","https://openalex.org/W2112397727","https://openalex.org/W2113901579","https://openalex.org/W2118559411","https://openalex.org/W2119429320","https://openalex.org/W2123629330","https://openalex.org/W2126065052","https://openalex.org/W2127409471","https://openalex.org/W2128592498","https://openalex.org/W2133572469","https://openalex.org/W2136752386","https://openalex.org/W2138045215","https://openalex.org/W2138451589","https://openalex.org/W2139366216","https://openalex.org/W2141362295","https://openalex.org/W2141946042","https://openalex.org/W2144125787","https://openalex.org/W2145335273","https://openalex.org/W2146333376","https://openalex.org/W2146901298","https://openalex.org/W2147779427","https://openalex.org/W2147817624","https://openalex.org/W2154865207","https://openalex.org/W2158727328","https://openalex.org/W2159205789","https://openalex.org/W2159243532","https://openalex.org/W2165698647","https://openalex.org/W2166173635","https://openalex.org/W2167621077","https://openalex.org/W2170439661","https://openalex.org/W2171294019","https://openalex.org/W2171512247","https://openalex.org/W2315098270","https://openalex.org/W2322256161","https://openalex.org/W2325963726","https://openalex.org/W2330845818","https://openalex.org/W2332595250","https://openalex.org/W2752336761","https://openalex.org/W2761395423","https://openalex.org/W3189636675","https://openalex.org/W3192932278","https://openalex.org/W4234408473","https://openalex.org/W4234825176","https://openalex.org/W4247067928"],"related_works":["https://openalex.org/W1967754898","https://openalex.org/W1916480346","https://openalex.org/W1681939708","https://openalex.org/W2048981028","https://openalex.org/W20782350","https://openalex.org/W2109468903","https://openalex.org/W2038915028","https://openalex.org/W2109688740","https://openalex.org/W2123355624","https://openalex.org/W1985523042"],"abstract_inverted_index":{"Type":[0],"2":[1,40,70],"diabetes":[2],"mellitus":[3],"traditionally":[4],"has":[5],"been":[6,168],"characterized":[7],"by":[8],"insulin":[9],"resistance":[10],"and":[11,17,20,49,56,64,93,130,144,150,176,194],"beta-cell":[12,148,152],"dysfunction,":[13],"leading":[14],"to":[15,44,146,165,201],"hyperglycemia":[16],"eventual":[18],"micro-":[19],"macrovascular":[21],"complications.":[22],"Dipeptidyl":[23],"peptidase-4":[24],"(DPP-4)":[25],"inhibitors":[26,112],"are":[27,134],"a":[28,46,74,107,203,229],"relatively":[29],"new":[30],"class":[31,162,251],"of":[32,38,51,58,68,84,88,99,121,125,174,206,214,219,237,252,261],"drugs":[33],"available":[34],"for":[35,79,96,181,226,232],"the":[36,52,59,66,85,89,97,110,256],"management":[37],"type":[39,69],"diabetes.":[41],"In":[42],"order":[43],"provide":[45],"comprehensive":[47],"evaluation":[48],"comparison":[50],"pharmacology,":[53],"pharmacokinetics,":[54],"efficacy,":[55,215],"safety":[57,177],"DPP-4":[60,111,208,233],"inhibitors-sitagliptin,":[61],"vildagliptin,":[62],"saxagliptin,":[63],"alogliptin-in":[65],"treatment":[67],"diabetes,":[71],"we":[72],"conducted":[73],"MEDLINE":[75],"search":[76],"(1966-July":[77],"2009)":[78],"pertinent":[80],"English-language":[81],"articles.":[82],"Abstracts":[83],"annual":[86],"meetings":[87],"American":[90],"Diabetes":[91,100],"Association":[92,95],"European":[94],"Study":[98],"from":[101,160,191],"2005-2009":[102],"were":[103],"also":[104],"searched.":[105],"As":[106],"drug":[108,253],"class,":[109],"have":[113,163],"become":[114,179,186],"widely":[115],"accepted":[116],"in":[117,172,212],"clinical":[118,155,220,247,257],"practice":[119],"because":[120],"their":[122],"low":[123],"risk":[124],"hypoglycemia,":[126],"favorable":[127],"adverse-effect":[128],"profile,":[129],"once-daily":[131],"dosing.":[132],"They":[133],"weight":[135,140],"neutral":[136],"(do":[137],"not":[138,199],"cause":[139],"gain":[141],"or":[142,217],"loss)":[143],"appear":[145,200],"decrease":[147],"apoptosis":[149],"increase":[151],"survival.":[153],"Because":[154],"studies":[156,244],"directly":[157],"comparing":[158],"agents":[159,185,227],"this":[161,250],"not,":[164],"our":[166],"knowledge,":[167],"conducted,":[169],"making":[170],"comparisons":[171],"terms":[173,213],"efficacy":[175],"will":[178,254],"difficult":[180],"clinicians":[182],"as":[183],"more":[184],"available.":[187],"Based":[188],"on":[189],"information":[190],"preclinical,":[192],"clinical,":[193],"postmarketing":[195],"data,":[196],"there":[197],"does":[198],"be":[202],"compelling":[204],"advantage":[205],"one":[207,262],"inhibitor":[209],"over":[210,264],"another":[211],"safety,":[216],"ease":[218],"use.":[221],"Although":[222],"theoretical":[223],"advantages":[224],"exist":[225],"with":[228,241,249],"higher":[230],"specificity":[231],"inhibition":[234,236],"versus":[235],"other":[238],"isoenzymes":[239],"associated":[240],"toxicity,":[242],"comparative":[243],"and/or":[245],"increased":[246],"experience":[248],"determine":[255],"advantages,":[258],"if":[259],"any,":[260],"agent":[263],"another.":[265]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1991969856","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":17}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
